Your Health, We Care

Home >Drug List>Elafibranor>Indications of Elafibranor

Elafibranor(Iqirvo)

Release date: 2026-01-05 14:32:12     Recommended: 55

It is indicated for the treatment of adult patients with primary biliary cholangitis who have an inadequate response to or intolerance of ursodeoxycholic acid.